Nathan Wong

Sep 28, 2024 | medrxiv.org | Kevin Tang |Jeffrey Jones |Wenjun Fan |Nathan Wong

The authors have declared no competing interest. Support was provided by the Stanley S. Franklin MD Memorial Endowment Fund for Hypertension and Heart Disease Prevention Research from the University of California, Irvine. I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Feb 27, 2024 | healio.com | Erik Swain |Richard Smith |Steven Nissen |Nathan Wong

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: High levels of lipoprotein(a) are associated with elevated risk for an adverse heart event. The relationship was consistent regardless of whether patients had atherosclerotic heart disease at baseline.

Dec 14, 2023 | healio.com | Regina Schaffer |Erik Swain |Nathan Wong

You've successfully added Endocrinology: Cardiometabolic Disorders to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Diabetes is not a CVD risk equivalent, making an accurate CV risk assessment critical.

May 16, 2023 | nature.com | Nathan Wong |Naveed Sattar

AbstractCardiovascular diseases (CVDs) are the leading causes of morbidity and mortality in individuals with type 2 diabetes mellitus (T2DM). Secular changes in CVD outcomes have occurred over the past few decades, mainly due to a decline in the incidence of ischaemic heart disease. The onset of T2DM at a young age (<40 years), leading to a greater number of life-years lost, has also become increasingly common.